NICE Ltd. (NCSYF) director reports initial share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
NICE Ltd. director Ben-Shaoul Rimon filed an initial Form 3 reporting his equity holdings in the company. He directly owns 995 Ordinary Shares and a series of employee stock options over additional Ordinary Shares with varying exercise prices and expiration dates.
These options include grants exercisable for 3,980 shares at an exercise price of 151.6300 per share expiring on April 30, 2026, and others such as 2,785 shares at 224.1800 per share expiring on September 10, 2026. Footnotes state that some options are fully vested and currently exercisable, while others vest in installments through September 30, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
14 transactions reported
Mixed
14 txns
Insider
Ben-Shaoul Rimon
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options — 3,980 shares (Direct);
Ordinary Shares — 995 shares (Direct)
Footnotes (1)
- The stock option is fully vested and currently exercisable. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026. The stock option will vest on September 30, 2026.
FAQ
What does Ben-Shaoul Rimon’s Form 3 filing show for NICE Ltd. (NCSYF)?
The Form 3 shows director Ben-Shaoul Rimon’s initial equity holdings in NICE Ltd., including 995 Ordinary Shares and multiple stock option awards. These options cover additional Ordinary Shares at specified exercise prices and expiration dates, reflecting his existing compensation-related exposure to the company’s stock.
What stock option positions are reported for Ben-Shaoul Rimon in NICE Ltd. (NCSYF)?
The filing lists several stock options over Ordinary Shares with different exercise prices and expirations, such as 3,980 underlying shares at 151.6300 expiring April 30, 2026. Each line describes a specific grant, indicating his potential future rights to acquire NICE Ordinary Shares.
Are Ben-Shaoul Rimon’s NICE Ltd. (NCSYF) options currently vested or still vesting?
Footnotes state that at least one stock option is fully vested and currently exercisable. Another option is vested and exercisable for 746 Ordinary Shares, with remaining shares vesting in three equal installments on March 30, 2026, June 30, 2026 and September 30, 2026, while another will vest on September 30, 2026.
Does the NICE Ltd. (NCSYF) Form 3 show any recent insider buying or selling by Ben-Shaoul Rimon?
The Form 3 presents holdings rather than new buy or sell transactions. Transaction codes are unknown and the entries are classified as holdings, indicating a snapshot of his existing Ordinary Share and option positions, not open-market purchases or sales activity.